The Byron Chemical Company business team combines more than 100 years of experience in the chemical, pharmaceutical, and nutritional ingredients industries. Their past and present functions range from R&D, Product Development, Regulatory, Sales & Purchasing, and Product & Project Management. Their experiences have enabled travels throughout the world bringing together a global network of sustainable business partners. We invite you to join our network as our industry continues to expand.

Nicholas Cola
President
Contact Nicholas Cola
Mr. Cola is actively involved in new growth strategies for the company that include alliances or agencies that complement our core business of supplying active pharmaceutical ingredients. He has been with the firm for over 35 years. Under his direction, Mr. Cola continually reviews and approves various plans brought forth by his business team.

Victor Rosenzweig
Vice President, Sales & Market Development
Contact Victor Rosenzweig
Victor’s primary focus is on contract development and review, preliminary site inspections, veterinary market and product life cycle management. Victor’s experience ranges from QC to materials management to sales and market development.

Jacob Ter Avest
Director, Sales & Business Development
Contact Jacob Ter Avest
Jacob’s main focus is on API supplier development, product life-cycle management, sales and marketing and customer relations. Previously, Jacob worked in quality control, purchasing, sourcing and sales and marketing

Adria Keleman
Manager, Sales & Project Development
Contact Adria Keleman
Adria’s main focus is on sales/marketing of API’s, customer/supplier development and product life-cycle management. Adria’s prior experiences include quality control, analytical method development and sales/marketing

Dwayne Sharpe
Regional Sales Manager
Contact Dwayne Sharpe
Dwayne’s main focus is on finished dose formulations including respiratory products in metered dose inhalers. Dwayne has more than ten years of sales and business development experience in the pharmaceutical manufacturing industry.